Vejle Sygehus
In research, Vejle Sygehus stands highest in Health Sciences (#5,395 of 11,982 worldwide) and Medicine (#4,996 of 10,443 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 9.2× its share of world research.
- World rank, 2022–2025
- #13,031 of 28,054 · #12,659 all time
- Rank in Denmark
- #47 of 108
- Research works
- 2.2k ▼ 18% vs 2013–17
- Citations
- 29k 12.8 per fractional work
- Top-10% rate
- 13.7% record average 16.5%
- Open access
- 22% world 28%
What is Vejle Sygehus known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #5,395 of 11,982 | 12.6% | 148 | #4506 | |
| MedicineField | #4,996 of 10,443 | 12.4% | 135 | #3680 |
Each strip is that field’s whole ranked pool, with the notch where Vejle Sygehus sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Vejle Sygehus specialise in?
Where its research is concentrated relative to its size: Oncology takes 9.2× the share of its output that it takes of world research.
- OncologySubfield · 20.6 works9.2×
- Pulmonary and Respiratory MedicineSubfield · 22.1 works7.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 6.3×. Every wedge is a field page.
- Veterinary 6.3×
- Medicine 3.5×
- Immunology and Microbiology 2.8×
- Health Professions 1.8×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Nursing 1.1×
- Pharmacology, Toxicology and Pharmaceutics 0.9×
- Psychology 0.6×
- Physics and Astronomy 0.5×
- Neuroscience 0.5×
- Decision Sciences 0.4×
- Economics, Econometrics and Finance 0.3×
- Energy 0.3×
- Dentistry 0.3×
- Agricultural and Biological Sciences 0.2×
- Social Sciences 0.2×
- Engineering 0.2×
- Business, Management and Accounting 0.2×
- Environmental Science 0.2×
- Earth and Planetary Sciences 0.1×
- Arts and Humanities 0.1×
- Computer Science 0.1×
- Chemical Engineering 0.1×
- Chemistry 0.1×
- Mathematics 0.1×
- Materials Science 0.0×
Who are the top researchers at Vejle Sygehus?
Ranked on the composite score, Jean‐Marie Delaissé, Flemming Brandt Sørensen and Torben Plesner lead among researchers whose main affiliation is Vejle Sygehus.
- 1 Jean‐Marie Delaissé Denmark · #41,946 worldwide 267 citations · 59 works
- 2 Flemming Brandt Sørensen Denmark · #227,908 worldwide 113 citations · 37 works
- 3 Torben Plesner Denmark · #316,781 worldwide 153 citations · 59 works
- 4 Per Kjærsgaard‐Andersen Denmark · #614,904 worldwide 65 citations · 32 works
- 5 Wulff Hr Denmark · #751,695 worldwide 19 citations · 16 works
- 6 Anders Jakobsen Denmark · #987,622 worldwide 74 citations · 113 works
- 7 Charlotte Kristiansen Denmark · #1,147,387 worldwide 14 citations · 21 works
- 8 Lars Henrik Jensen Denmark · #1,235,950 worldwide 25 citations · 45 works
- 9 Rikke Fredslund Andersen Denmark · #1,305,015 worldwide 30 citations · 40 works
- 10 Larsen Jf Denmark · #1,323,271 worldwide 2 citations · 17 works
Which keywords describe research at Vejle Sygehus?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Clinical Practice Guidelines, Diagnosis, Radiotherapy, Quality of Life, Inflammation and Treatment.
- Screening
- Cancer Risk
- Somatic Mutations
- Laparoscopic Surgery
- Tumor Staging
- Genomic Profiling
- Tumor Markers
- Health-related Quality of Life
- Prognostic Factors
- Metastasis
- COPD
- Genomic Instability
- Adjuvant Chemotherapy
- Global Burden
- Clinical Trials
- Risk Factors
- Radiotherapy
- Treatment
- Quality of Life
- Chemotherapy
- Epidemiology
- Inflammation
- Diagnosis
- Clinical Practice Guidelines
- Management
- Targeted Therapy
- Immunotherapy
- Neoadjuvant Therapy
- Tumor Microenvironment
- Prevention
- spirometry
- Precision Medicine
- Rituximab
- Lymphoma
- Adjuvant Therapy
- Molecular Subtypes
- Cell-Free DNA
- PET Imaging
- Cancer Genomics
- Mutational Signatures
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology22▲ 2.7×72 topics
- Chemotherapy12▲ 8.6×20 topics
- Inflammation12▲ 2.8×39 topics
- Quality of Life11▲ 3.7×32 topics
- Diagnosis10▲ 5.4×24 topics
- Treatment10▲ 4.0×30 topics
- Clinical Practice Guidelines9▲ 8.3×14 topics
- Radiotherapy8▲ 11×11 topics
- Management8▲ 5.2×16 topics
- Risk Factors8▲ 3.8×20 topics
- Targeted Therapy7▲ 16×5 topics
- Clinical Trials6▲ 4.8×13 topics
- Immunotherapy6▲ 4.5×12 topics
- Global Burden6▲ 5.9×8 topics
- Neoadjuvant Therapy6▲ 12×5 topics
- Adjuvant Chemotherapy5▲ 33×2 topics
- Tumor Microenvironment4▲ 5.1×8 topics
- Genomic Instability4▲ 19×2 topics
- Prevention4▲ 5.1×11 topics
- COPD4▲ 32×1 topic
- spirometry4▲ 32×1 topic
- Metastasis4▲ 6.0×9 topics
- Precision Medicine4▲ 4.3×5 topics
- Prognostic Factors4▲ 4.6×11 topics
- Rituximab4▲ 13×4 topics
- Health-related Quality of Life4▲ 8.2×4 topics
- Lymphoma4▲ 12×3 topics
- Tumor Markers4▲ 24×2 topics
- Adjuvant Therapy4▲ 14×2 topics
- Genomic Profiling4▲ 17×2 topics
- Molecular Subtypes3▲ 20×3 topics
- Tumor Staging3▲ 15×2 topics
- Cell-Free DNA3▲ 17×2 topics
- Laparoscopic Surgery3▲ 14×3 topics
- PET Imaging3▲ 9.7×4 topics
- Somatic Mutations3▲ 20×2 topics
- Cancer Genomics3▲ 22×1 topic
- Cancer Risk3▲ 7.4×6 topics
- Mutational Signatures3▲ 22×1 topic
- Screening3▲ 17×3 topics
Which research topics does Vejle Sygehus publish most on?
By volume in 2022–2025: Chronic Obstructive Pulmonary Disease (COPD) Research, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment and Colorectal Cancer Surgical Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 4 works
- 2 Cancer Genomics and Diagnostics Cancer Research 3 works
- 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
- 4 Colorectal Cancer Surgical Treatments Oncology 3 works
- 5 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 7 Cancer survivorship and care Oncology 2 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 9 Ophthalmology and Visual Impairment Studies Epidemiology 2 works
- 10 Colorectal Cancer Treatments and Studies Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Vejle Sygehus's research output changed?
Output in 2018–2022 was 18% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Vejle
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.